EryDel raises 26 mln euros
EryDel has raised 26 million euros ($31.7 million) in financing led by Sofinnova Partners. Existing shareholders Genextra SpA and Innogest SGR also participated to the investment. EryDel, of Milan, is developing a drug delivery device for the treatment of rare neurodegenerative diseases.
24 April 2018•2 mins read
